rawfin.tv
Twist Bioscience Stock Evaluation Revised Amid Market Volatility
MarketsstocksAI Generated

Twist Bioscience Stock Evaluation Revised Amid Market Volatility

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Twist Bioscience Corp. (TWST), a small-cap biotechnology company, is undergoing a revision in its stock evaluation. The firm's shares are currently experiencing notable volatility, trading around $44.

BiotechnologySmall CapStock VolatilityMarket DynamicsHealthcare

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks